CEC SpA

Ñuñoa 7750495

0 studies enrolling now · 1 studies all time

What they study most

Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement

Studies at this site

• A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease — Stopped early